Oversold

ACAD

Valuation58/ 100
Cash flow & growth58/ 100
Upside potential51/ 100
Risk potential25/ 100

ACAD's valuation appears fair, fundamentals are somewhat mixed and weaker than expected earnings are holding it back, though estimates vary widely.

Score change since last week

The score rose 2 points, mainly due to valuation and price changes. Price fell 3.7%, from $29.11 to $28.02. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 2.7 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 12.5× versus the full-history median of 15.9× shown in the valuation table, producing 61.2/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 57.6/100. The model applies a 1.4% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 15.2× (18-month half-life). The favorable scenario uses 14.2× PE and $2.4 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +11.8%, earnings +66.9%, operating margin -15.7 percentage points. Free cash flow is 15.3% of revenue. The business score is 57.5/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $2.43 of EPS and a 14.2× PE, suggesting a share price of about $34.51 — 24% above today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $1.87 of EPS and a 11.2× PE, suggesting a share price of about $20.94 — 25% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

ACAD vs Historical averages

MetricCurrentAverageRelative
PE13x24x47% lower
PE percentile285045% lower
EPS$2.22-$0.32$2.54 higher
FCF$174.4M-$4.9M+$179.3M
Loading historical comparisons…

ACAD’s earnings are above their historical averages, while its earnings multiple is lower.

ACAD Forward outlook

MetricOutlook
Forward valuationStrongly deteriorating
Forward earningsStrong decline
Forward revenueStrong growth
Forward profitabilityExpanding
Analyst coverageModerate
Estimate dispersionWide

ACAD’s outlook is mixed, with weaker expected earnings weighing on the picture.

ACAD PE Valuation

Loading pe valuation table…

This table applies ACAD's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

ACAD Earnings Per Share

Loading earnings per share…

This chart tracks ACAD's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

ACAD Quarterly Revenue

Loading quarterly revenue…

This chart tracks ACAD's quarterly revenue over time and shows how sales are changing from year to year.

ACAD Free Cash Flow

Loading free cash flow…

This chart tracks ACAD's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

ACAD Total Shares

Loading shares over time…

This chart tracks changes in ACAD's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

ACAD Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

ACAD PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares ACAD's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

ACAD Weekly Price

Loading weekly price…

This chart uses ACAD's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

ACAD Weekly Moving Averages

Loading weekly moving averages…

This chart compares ACAD's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

ACAD Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

UNH

Same as last week
Valuation47/ 100
Cash flow & growth46/ 100
Upside potential49/ 100
Risk potential31/ 100

UNH's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to earnings growth and improving margins.

Valuation

Historical cheapness: current PE is 24.4× versus the full-history median of 21.5× shown in the valuation table, producing 41.5/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 46.9/100. The model applies a 21.8% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 22.4× (18-month half-life). The favorable scenario uses 24.6× PE and $20.4 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +6.5%, earnings -32.6%, operating margin -2.5 percentage points. Free cash flow is 5.2% of revenue. The business score is 45.6/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $20.39 of EPS and a 24.6× PE, suggesting a share price of about $500.50. Valuation history and outlook inform the PE.

The displayed favorable scenario is 32% upside, or about $500.40.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $13.45 of EPS and a 19.6× PE, suggesting a share price of about $262.95 — 31% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

UNH vs Historical averages

MetricCurrentAverageRelative
PE24x23x8% higher
PE percentile715042% higher
EPS$15.55$18.6717% lower
FCF$23.6B$21.7B9% higher
Loading historical comparisons…

UNH’s fundamentals are mixed relative to their historical averages, while its earnings multiple is higher.

UNH Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueStable
Forward profitabilityExpanding
Analyst coverageModerate
Estimate dispersionModerate

UNH’s outlook is generally improving, with growth expectations supporting the valuation case.

UNH PE Valuation

Loading pe valuation table…

This table applies UNH's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

UNH Earnings Per Share

Loading earnings per share…

This chart tracks UNH's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

UNH Quarterly Revenue

Loading quarterly revenue…

This chart tracks UNH's quarterly revenue over time and shows how sales are changing from year to year.

UNH Free Cash Flow

Loading free cash flow…

This chart tracks UNH's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

UNH Total Shares

Loading shares over time…

This chart tracks changes in UNH's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

UNH Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

UNH PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares UNH's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

UNH Weekly Price

Loading weekly price…

This chart uses UNH's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

UNH Weekly Moving Averages

Loading weekly moving averages…

This chart compares UNH's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

UNH Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.